National Bioethics Committee Guidelines For Healthcare Professionals interaction with Pharma trade and industry

Jawaid, Shaukat Ali; Jafary, Maqbool H.; Khan, Farid; Hashmi, Sohail Karim
July 2010
Pakistan Journal of Medical Sciences;Jul2010, Vol. 26 Issue 3, p503
Academic Journal
The article discusses the guidelines on how medical professionals could interact with those in the pharmaceutical trade and industry in Pakistan. It mentions that the guidelines would monitor the interaction between physicians and those in the pharmaceutical industry. It states that medical professionals should maintain professional independence in the interest of the patients, while avoiding self interest in prescribing. Furthermore, the government had introduced legislation with penalties to control those unethical practices.


Related Articles

  • Doctors told to shun rewards from industry as size of payments become clear. Charatan, Fred // BMJ: British Medical Journal (International Edition);2/4/2006, Vol. 332 Issue 7536, p255 

    The author describes a leading article in the "Journal of the American Medical Association" which advises doctors to shun gifts from pharmaceutical companies, who spend more than $20 billion a year on advertising. Evidence suggests that the size of the gift doesn't matter in influencing doctor...

  • PhRMA Takes a Wait-and-See Approach To a Medicare Prescription Drug Plan. Hess, Glenn // Chemical Market Reporter;07/05/99, Vol. 256 Issue 1, p1 

    Reveals the reaction of research-based pharmaceutical and biotechnology companies on the proposed additional prescription drug benefit of United States President Bill Clinton to the Medicare program. Support of the industry on the proposal; Information on the drug benefit policy; Significance...

  • Americans make risky healthcare trade-offs to save money.  // PharmacoEconomics & Outcomes News;10/29/2011, Issue 640, p2 

    The article suggests that doctors consider the financial interests of their patients after respondents in a poll conducted by the U.S. Consumer Reports Health Ratings Center expressed their misgivings about the influence of the pharmaceutical industry on the prescribing practices of their doctors.

  • Expectations vs. Reality. Stern, Philip; Ehrenberg, Andrew // Marketing Research;Spring2003, Vol. 15 Issue 1, p40 

    Focuses on the stages of evidence on how doctors prescribe. Way to increase the sales of drugs according to a survey of European pharmaceutical marketing managers; Differences in the way drugs are prescribed.

  • Preparing for practice Handling drug reps. Spence, Des // Update;6/16/2005, Vol. 70 Issue 6, p80 

    This article presents information on influential parliamentary report that could heavily restrict the influence of pharmaceutical firms on drug prescribing in Great Britain. A recent report by the House of Commons Health Committee on the influence of the pharmaceutical industry made wide-ranging...

  • Can a Nice distinction end a messy NHS? Boseley, Sarah // Public Finance;07/09/99, p16 

    Explains why doctors and drug companies are apprehensive about the functions of the National Institute for Clinical Excellence (Nice) in Great Britain. Assessment of new drugs entering the market as one of the main functions of Nice; Creation of Nice to end the free market in the National...

  • Restrictions on NHS prescribing in Australia. Smith, Tony // British Medical Journal;1/13/1979, Vol. 1 Issue 6156, p99 

    Focuses on the acceptance of doctors regarding the restrictions on medicine prescription in Australia. Requirement of the Australian medical care; Aim of the pharmaceutical benefits scheme; Influence of politics for the evolvement of the scheme.

  • GPs have 'unhealthy' relationship with reps.  // Pulse;6/2/2003, Vol. 63 Issue 22, p4 

    Reports on the criticism of journal 'BMJ' on the relationship between pharmaceutical industry and general practitioners on drug prescription consequences for patients in Great Britain.

  • Pharmaceutical Companies Influence Prescribing.  // People's Medical Society Newsletter;Apr2000, Vol. 19 Issue 2, p4 

    Shows how pharmaceutical companies affects physicians and how they influence prescription drugs through direct-to-consumer advertising.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics